Column 13

Rib Remodeling for Trans Women: Surgery on Estrogen and Blood Clot Prevention

What hormones change and what they do not, whether to stop estrogen, and what we still do not know

Some transgender women (trans women) ask about rib remodeling because of their waist contour. Hormone therapy changes where fat is stored, but it does not change the length or angle of the ribs in adulthood. Whether surgery is worth considering depends on what shapes the waist and on overall health, not on gender identity. For anyone on hormone therapy, blood clot risk needs to be planned from before surgery through recovery and the journey home.

This article is not written to recommend surgery. It answers questions we hear in consultation, with the research behind each answer. We should say first that research on rib remodeling in trans women is still very limited.

What hormone therapy changes, and what it does not

Feminizing hormone therapy changes where the body stores fat. In a prospective study at several European university hospitals that followed 179 trans women for one year, body fat increased by 18% in the abdominal (android) region, 34% in the hip (gynoid) region and 42% in the legs. The waist-to-hip ratio fell by an average of 0.03, mainly because hip circumference grew by an average of 3.2 cm rather than because the waist became smaller.1

The length and angle of the ribs, by contrast, are part of the skeleton that is set after puberty. There is no evidence that hormone therapy started in adulthood changes the direction of the lower ribs. This is why, even after years of hormone therapy, the width above the waist, at the lower edge of the rib cage, can remain.

  • If hormone therapy started recently, it is reasonable to assess the remaining contour after fat redistribution has had time to progress.
  • Fat, abdominal wall muscle and rib angle all contribute to the waist. Examination and CT help separate which one matters most.

→ Column 03 explains why the waistline can stay the same after weight loss

Research in trans women is still limited

A 2026 case report described one 30-year-old trans woman who had breast augmentation together with rib remodeling of the 10th to 12th ribs using the RibXcar technique. At four months, CT showed reduced spacing between the ribs, waist circumference had changed from 77 cm to 67 cm and the waist-to-hip ratio from 0.9 to 0.8, and no respiratory complications were reported.2

A retrospective study published the same year reviewed 52 trans women who had combined liposuction, gluteal augmentation and rib remodeling. The waist-to-hip ratio fell by an average of 32%, but three thromboembolic events (5.7%) were identified.3

Both reports describe patients who had other procedures at the same time, and neither has a comparison group. There is not yet data that isolates the effect or safety of rib remodeling alone. Nor is there enough evidence to say that it suits trans women especially well, or that it is especially risky for them.

Removing ribs versus changing their angle

Surgery that removes part of the lower ribs for waist contour also exists. Removed bone does not grow back, so it is important to understand that this cannot be reversed before deciding. RIBXCAR keeps the ribs and changes their angle by cutting only the outer cortex. The bone still has to heal, a brace and follow-up visits are needed, and keeping the ribs does not mean there are no complications.

→ Column 06 explains the difference between rib removal and rib preservation

Do I need to stop estrogen before surgery?

Surgery and estrogen are each risk factors for venous blood clots. For this reason, many surgeons used to ask patients to stop hormones one to four weeks before surgery. However, there is little evidence to support stopping as a blanket rule.

A US academic center reviewed 919 patients who had gender-affirming surgery. Among trans women having vaginoplasty, estrogen was paused for one week before surgery in 190 cases and continued in 212 cases. There was one venous blood clot, and it occurred in the group that had paused estrogen. None occurred in the group that continued (mean follow-up 285 days).4

This was, however, a single-center study of vaginoplasty patients who all received the same clot prevention. It cannot be applied directly to body contouring that combines liposuction or other procedures. A 2023 review in an endocrinology journal noted that clot risk varies with the type, dose, route and duration of estrogen, with transdermal forms carrying the lowest risk. It also noted that existing clot risk scores do not account for hormone therapy, so risk has to be assessed individually.5

So rather than stopping or continuing estrogen as a blanket rule, the decision is made together with the clinician who prescribes it, based on individual risk factors. Please do not stop or change your dose on your own, and bring the name, dose and route of your medication to the consultation.

Blood clots are also an aftercare issue

In the 52-patient study above, two of the three events were deep vein clots in the leg without symptoms, found on Doppler ultrasound performed on scheduled days. The third was a pulmonary embolism that occurred after long-haul travel earlier than advised.3

  • Combining more procedures in one session can lengthen operating time and recovery. The scope and order of any combined procedures should be planned together.
  • For patients travelling from abroad, the flight home is part of clot management. Please discuss it in consultation before booking your ticket.
  • If one leg suddenly swells or hurts, or you become short of breath or have chest pain after surgery, contact the clinic or emergency care immediately.

Bone healing and hormones

RIBXCAR relies on bone healing after an incomplete fracture. Sex hormones affect bone mineral density, and a multicenter study found that bone mineral density increased in trans women after one year of hormone therapy.6 If you have had periods when hormone therapy was stopped or irregular, please mention it. Where needed, bone density and the recovery plan are reviewed together.

What to check in consultation

  • How long you have been on hormone therapy; the medication, dose and route (tablet, patch, gel or injection); and who prescribes it
  • Any personal or family history of blood clots, smoking, and recent long-distance travel
  • Other procedures you are planning (breast, liposuction, gluteal and so on) and their order
  • Whether your waist contour comes mainly from fat, muscle or the angle of the lower ribs
  • Brace use and follow-up schedule, and for international patients, when you plan to fly home

We do not recommend for or against rib remodeling because someone is a trans woman. The decision depends on where the waist contour comes from, and on overall health, including hormone therapy and clot risk.

References

  1. Klaver M, de Blok CJM, Wiepjes CM, et al. Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study. Eur J Endocrinol. 2018;178(2):163-171. doi:10.1530/EJE-17-0496
  2. González-Arestizábal T, Kohnenkampf R, Domínguez C. Rib remodeling as a thoracic feminization strategy in transfeminine patients: Case report. JPRAS Open. 2026;49:349-354. doi:10.1016/j.jpra.2026.02.018
  3. Aslani A, Frontado G, Arani A. Body Feminization Surgery 4.0: Do We Need a Safety Update? Aesthetic Plast Surg. 2026;50(20):8322. doi:10.1007/s00266-026-06206-2
  4. Kozato A, Fox GWC, Yong PC, et al. No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender-Affirming Surgery. J Clin Endocrinol Metab. 2021;106(4):e1586-e1590. doi:10.1210/clinem/dgaa966
  5. Arrington-Sanders R, Connell NT, Coon D, et al. Assessing and Addressing the Risk of Venous Thromboembolism Across the Spectrum of Gender Affirming Care: A Review. Endocr Pract. 2023;29(4):272-278. doi:10.1016/j.eprac.2022.12.008
  6. Wiepjes CM, Vlot MC, Klaver M, et al. Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study. J Bone Miner Res. 2017;32(6):1252-1260. doi:10.1002/jbmr.3102

※ Rib remodeling is elective aesthetic surgery. Suitability and results vary with individual anatomy and health. Decisions should be made after examination, tests and a full discussion with your medical team. Any change to hormone therapy should be discussed with the clinician who prescribes it.

→ What is RIBXCAR?
→ Possible complications
→ Consultation